Editor-in-Chief
Janice M. Reichert
Boston, MA, US
Associate Editor
Alain Beck
Centre d'Immunologie Pierre Fabre (CIPF)
St Julien-en-Genevois, FR
Assistant Editor
Qiangwei Xia
Regeneron Pharmaceuticals, Inc.
Analytical Chemistry, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road
Tarrytown, NY, USA 10591
Editorial Board
- Gregory P. Adams
-
Fox Chase Cancer Center
Philadelphia, PA, US
- Nasimul Ahsan
-
W.G. "Bill" Hefner VA Medical Center
Salisbury, NC, US
- Ashraf Amanullah
-
Genentech, Inc.
Oceanside, CA, US
- Taruna Arora
-
Amgen
Thousand Oaks, CA, US
- Laurent P. Audoly
-
Pieris AG
Freising, DE
- Joseph P. Balthasar
-
University of New York at Buffalo
Buffalo, NY, US
- Richard Begent
-
University College London
London, UK
- Detlev Biniszkiewicz
-
Novartis Institutes for Biomedical Research
Cambridge, MA, US
- Sally Bolmer
-
Human Genome Sciences
Rockville, MD, US
- Pavel V. Bondarenko
-
Amgen
Thousand Oaks, CA, US
- Arindam Bose
-
Pfizer
New London, CT, US
- Andrew Bradbury
-
Los Alamos National Laboratory
Los Alamos, NM, US
- John C. Byrd
-
The Ohio State University
Columbus, OH, US
- Paul J. Carter
-
Genentech
Oceanside, CA, US
- Ravi J. Chari
-
ImmunoGen, Inc.
Waltham, MA, null
- Michael Chartrain
-
Merck & Co., Inc.
Rahway, NJ, US
- Mike Clark
-
Cambridge University
Cambridge, UK
- Ralph Clynes
-
Columbia University
New York, NY, US
- Nathalie Corvaia
-
Centre d'Immunologie Pierre Fabre (CIPF)
St Julien-en-Genevois, FR
- Graeme Currie
-
Regeneron Pharmaceuticals
Tarrytown, NY, US
- John R. Desjarlais
-
Xencor, Inc.
Monrovia, CA, US
- Dimiter S. Dimitrov
-
National Institutes of Health
Frederick, MD, US
- Donald Drakeman
-
Advent Venture Partners
London, UK
- Stefan Dübel
-
Technische Universität Braunschweig
Braunschweig, DE
- Charles Dumontet
-
Université de Lyon
Lyon, FR
- Martin Glennie
-
University of Southampton
Southampton, UK
- Iqbal S. Grewal
-
ImmunGene Inc.
Thousand Oaks, CA, US
- Yajun Guo
-
PLA General Hospital Cancer Center
Beijing, CN
- Sherif Hanala
-
Bio-Rad Laboratories
Hercules, CA, US
- Raffit Hassan
-
National Cancer Institute
Bethesda, MD, US
- Mitchell Ho
-
National Institutes of Health
Bethesda, MD, US
- P. Mark Hogarth
-
Burnet Institute
Melbourne, AU
- James S. Huston
-
The Antibody Society
Newton, MA, US
- Roy Jefferis
-
University of Birmingham
Birmingham, UK
- Roland E. Kontermann
-
Universität Stuttgart
Stuttgart, DE
- Denny Kraichely
-
Johnson & Johnson/Centocor
New Brunswick, NJ, US
- Gaurav Laroia
-
MSD Pharmaceuticals Pvt. Ltd.
Mumbai, IN
- Marie-Paule Lefranc
-
Université Montpellier II
Montpellier, FR
- Nils Lonberg
-
Brisol-Myers Squibb/Medarex
Princeton, NJ, US
- Henry Lowman
-
CytomX Therapeutics, Inc.
South San Francisco, CA, US
- James D. Marks
-
University of California at San Francisco
San Francisco, CA, US
- John L. Marquardt, Jr.
-
Marquardt Law
Washington, D.C., US
- R.A. Mashelkar
-
National Chemical Laboratory
Pune, IN
- Richard Mason
-
BTG Group
London, UK
- Kiran Mazumdar Shaw
-
Biocon Ltd.
Bangalore, IN
- John McCafferty
-
Cambridge University
Cambridge, UK
- Sherie Morrison
-
University of California at Los Angeles
Los Angeles, CA, US
- Jan Mueller-Berghaus
-
Paul-Ehrlich-Institute, Federal Agency for Sera and Vaccines
Langen, DE
- Bilikallahalli Muralidhara
-
MedImmume, LLC
Mountain View, CA, US
- Dario Neri
-
Swiss Federal Institute of Technology Zurich
Zurich, CH
- Jane Osbourn
-
MedImmune, Inc.
Cambridge, UK
- Gilles Paintaud
-
Université François-Rabelais
Tours, FR
- Paul Parren
-
Genmab
Utrecht, NL
- Ira Pastan
-
National Institutes of Health
Bethesda, MD, US
- André Pelegrin
-
Institut de Recherche en Cancérologie de Montpellier
Montpellier, FR
- Andreas Plückthun
-
University of Zurich
Zurich, CH
- Leonard Presta
-
Merck & Co., Inc.
Palo Alto, CA, US
- Vijay Ramakrishnan
-
Pikamab, Inc.
Menlo Park, CA, US
- Mitsuo Satoh
-
Kyowa Hakko Kirin
Tokyo, JP
- Christian K. Schneider
-
Paul-Ehrlich-Institute, Federal Agency for Sera and Vaccines
Langen, DE
- Jamie Scott
-
Simon Fraser University
Burnaby, BC, CA
- Marjorie Shapiro
-
US Food and Drug Administration
Washington, DC, US
- David Shen
-
Teva Pharmaceuticals
Horsham, PA, US
- Arne Skerra
-
Technische Universität München
Munich, DE
- William R. Strohl
-
J&J Biotechnology Center of Excellence
Radnor, PA, null
- Shanmuuga Sundaram
-
ImClone Systems, a wholly owned subsidiary of Eli Lilly & Co.
Branchburg, NJ
- Jean-Luc Teillaud
-
Centre de Recherche des Cordeliers/INSERM
Paris, FR
- Jan ter Meulen
-
Merck & Co., Inc.
North Wales, PA, US
- Pablo Umana
-
Glycart Biotechnology AG (Roche Group)
Zurich, CH
- Jan van de Winkel
-
Genmab
Copenhagen, DK
- E. Sally Ward
-
University of Texas Southwestern Medical Center
Dallas, TX, US
- Hervé Watier
-
Université François-Rabelais/CNRS
Tours, FR
- Louis M. Weiner
-
Georgetown University Medical Center
Washington, DC, US
- Gregory Winter
-
MRC Laboratory of Molecular Biology
Cambridge, UK
- K. Dane Wittrup
-
Massachusetts Institute of Technology
Boston, MA, US
- Clive R. Wood
-
Bayer Schering Pharma AG
Berlin-Wedding, DE
- Jenny M. Woof
-
University of Dundee Medical School
Dundee, UK
- Herren Wu
-
MedImmune
Cambridge, UK
- Thierry Wurch
-
Institut de Recherches Servier
Croissy sur Seine, FR
- Bodi Zhang
-
Tufts University
Boston, MA, US
Advertisements
